A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors.

Details

Language :

English

ISSN :

19420862

Volume :

12

Issue :

1

Database :

Complementary Index

Journal :

mAbs

Publication Type :

Academic Journal

Accession number :

148210135

Full Text :

https://doi.org/10.1080/19420862.2020.1773751